FDA recall D-0706-2026

Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6956-61

Reason for recall

Subpotent Drug

Distribution

Nationwide in the USA.

Key facts

Status

Ongoing

Initiation date

2026-07-13

Report date

2026-07-29

Voluntary/Mandated

Voluntary: Firm initiated

Location

Dublin, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0706-2026